Intravenous injection of the antibiotic delafloxacin, billed per 1 mg administered

This code represents the administration of delafloxacin, a novel fluoroquinolone antibiotic, typically given intravenously. It is primarily used for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible organisms. Delafloxacin offers broad-spectrum activity, including against methicillin-resistant Staphylococcus aureus (MRSA).

This code is used when billing for the drug product delafloxacin administered to a patient. It is appropriate for patients receiving treatment for severe skin and soft tissue infections requiring intravenous antibiotic therapy. Documentation should clearly indicate the drug name, dosage administered (in milligrams), and the route of administration.

• Report units based on 1 mg increments of delafloxacin administered.
• Ensure the medical record supports the medical necessity for intravenous delafloxacin, including the diagnosis and patient's clinical status.
• Do not confuse with other fluoroquinolone antibiotics; this code is specific to delafloxacin.